Ranjan Pai is among India’s most influential investors. So, when he makes a move into senior care, it is time to sit up and take notice of the sector, not to mention the broader grey economy.
Related Posts
Sun Pharma’s new drug to take on Pfizer, Eli Lilly is having a bad hair day.
Synopsis Last year, Sun Pharma infused over INR4,688 crore to buy US-based Concert Pharma. That deal gave it rights to…
How raising awareness about infertility is making IVF a USD4.6 billion opportunity
Infertility, once shrouded in cultural taboos and superstition, has emerged as a critical health issue worldwide. In India, the narrative…
Care este cel mai bun antiinflamator pentru durerile de spate?
antiinflamator pentru durerile de spate Durerea de spate este o problemă comună care afectează oameni de toate vârstele și poate…
